How Is The Market Feeling About Horizon Therapeutics?
Portfolio Pulse from Benzinga Insights
Horizon Therapeutics's (NYSE:HZNP) short percent of float has risen 20.52% since its last report, indicating increased bearish sentiment. The company has 9.48 million shares sold short, which is 4.17% of all regular shares available for trading. This is higher than the peer group average of 3.45%. However, increased short interest can sometimes be bullish for a stock.
September 18, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Increased short interest in Horizon Therapeutics indicates bearish market sentiment. However, this could potentially be bullish for the stock.
Short interest in Horizon Therapeutics has increased, indicating that traders are betting on the stock's price to fall. However, this can sometimes be a bullish indicator as it creates potential for a short squeeze, where the stock price increases due to short sellers buying to cover their positions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100